Answer
No. It is an immune-checkpoint inhibitor, although it may be given alongside chemotherapy or other anticancer treatments.
Sources for this answer
- Tecentriq 840 mg and 1,200 mg concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.